Inactivation of enveloped virus by laser-driven protein aggregation

Abstract. Ultrafast lasers in the visible and near-infrared range have emerged as a potential new method for pathogen reduction of blood products and pharmaceuticals. However, the mechanism of enveloped virus inactivation by this method is unknown. We report the inactivation as well as the molecular and structural effects caused by visible (425 nm) femtosecond laser irradiation on murine cytomegalovirus (MCMV), an enveloped, double-stranded DNA virus. Our results show that laser irradiation (1) caused a 5-log reduction in MCMV titer, (2) did not cause significant changes to the global structure of MCMV virions including membrane and capsid, as assessed by electron microscopy, (3) produced no evidence of double-strand breaks or crosslinking in MCMV genomic DNA, and (4) caused selective aggregation of viral capsid and tegument proteins. We propose a model in which ultrafast laser irradiation induces partial unfolding of viral proteins by disrupting hydrogen bonds and/or hydrophobic interactions, leading to aggregation of closely associated viral proteins and inactivation of the virus. These results provide new insight into the inactivation of enveloped viruses by visible femtosecond lasers at the molecular level, and help pave the way for the development of a new ultrafast laser technology for pathogen reduction.

[1]  G. Rock,et al.  Protein quality in Mirasol pathogen reduction technology–treated, apheresis‐derived fresh‐frozen plasma , 2010, Transfusion.

[2]  B. Lambrecht,et al.  Photoinactivation of Viruses in Human Fresh Plasma by Phenothiazine Dyes in Combination with Visible Light , 1991, Vox sanguinis.

[3]  A K Field,et al.  "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs , 1994, Clinical Microbiology Reviews.

[4]  Guy Boivin,et al.  Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[5]  Chien-Fu Hung,et al.  Inactivation of viruses by coherent excitations with a low power visible femtosecond laser , 2007, Virology Journal.

[6]  Kong-Thon Tsen,et al.  Prospects for a novel ultrashort pulsed laser technology for pathogen inactivation , 2012, Journal of Biomedical Science.

[7]  I. D. De Cuyper,et al.  UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3. , 2008, Blood.

[8]  Kong-Thon Tsen,et al.  Inactivation of viruses by laser-driven coherent excitations via impulsive stimulated Raman scattering process. , 2007, Journal of biomedical optics.

[9]  A. Prince,et al.  Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. , 1992, Blood.

[10]  J. Cazenave,et al.  An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment , 2010, Transfusion.

[11]  J. Shanley,et al.  The murine cytomegalovirus M25 open reading frame encodes a component of the tegument. , 1999, Virology.

[12]  P. Mintz,et al.  Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease. , 2006, Blood.

[13]  H. Einsele,et al.  Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. , 2011, The Lancet. Infectious diseases.

[14]  A. Ettinger,et al.  Characterization of plasma protein activity in riboflavin and UV light‐treated fresh frozen plasma during 2 years of storage at −30°C , 2010, Vox sanguinis.

[15]  L. Corash,et al.  Pharmacokinetic study of FFP photochemically treated with amotosalen (S‐59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin , 2002, Transfusion.

[16]  R. Rahn,et al.  Singlet oxygen involvement in ultraviolet (254 nm) radiation-induced formation of 8-hydroxy-deoxyguanosine in DNA. , 1997, Free radical biology & medicine.

[17]  R. Hai,et al.  Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame M35 Is Defective in Growth In Vivo , 2003, Journal of Virology.

[18]  J. George,et al.  A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh‐frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura , 2006, Transfusion.

[19]  E. Huang,et al.  The human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics , 1996, Journal of virology.

[20]  P. Dallas,et al.  Identification of the glycoprotein H gene of murine cytomegalovirus. , 1992, The Journal of general virology.

[21]  Y. Isashiki,et al.  Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir , 1997, Archives of Virology.

[22]  M. Fayer,et al.  Hydrogen Bond Dissociation and Reformation in Methanol Oligomers Following Hydroxyl Stretch Relaxation , 2002 .

[23]  H. Schuitemaker,et al.  Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates , 2007, Transfusion.

[24]  M. Waterfield,et al.  Proteomic analysis of UVC irradiation‐induced damage of plasma proteins: Serum amyloid P component as a major target of photolysis , 2006, FEBS letters.

[25]  U. Koszinowski,et al.  Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus , 1992, Journal of virology.

[26]  L. Corash,et al.  INTERCEPT plasma: comparability with conventional fresh‐frozen plasma based on coagulation function – an in vitro analysis , 2010, Vox sanguinis.

[27]  B. Barrell,et al.  Identification of the major capsid protein gene of human cytomegalovirus , 1989, Journal of virology.

[28]  D. Spector,et al.  Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins , 1996, Journal of virology.

[29]  V. Vicente,et al.  The influence of riboflavin photochemistry on plasma coagulation factors. , 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[30]  Shaw-Wei D Tsen,et al.  Selective inactivation of human immunodeficiency virus with subpicosecond near-infrared laser pulses , 2008 .

[31]  M. Blajchman,et al.  Proceedings of a Consensus Conference: Pathogen Inactivation—Making Decisions About New Technologies☆ , 2007, Transfusion Medicine Reviews.

[32]  W. Britt,et al.  Sequence analysis and expression of the murine cytomegalovirus phosphoprotein pp50, a homolog of the human cytomegalovirus UL44 gene product. , 1994, Virology.

[33]  Kong-Thon Tsen,et al.  Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser. , 2009, Journal of biomedical optics.

[34]  Travis J. Chapa,et al.  Murine Cytomegalovirus Targets Transcription Factor ATF4 To Exploit the Unfolded-Protein Response , 2012, Journal of Virology.

[35]  B. Fleckenstein,et al.  The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. , 1987, The Journal of general virology.

[36]  J. Loutsch,et al.  Cloning and sequence analysis of murine cytomegalovirus protease and capsid assembly protein genes. , 1994, Biochemical and biophysical research communications.

[37]  W. Freeman,et al.  Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. , 1998, Archives of ophthalmology.

[38]  Markus Wagner,et al.  Identification of Proteins Associated with Murine Cytomegalovirus Virions , 2004, Journal of Virology.

[39]  F. Baldanti,et al.  Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients , 1995, Journal of medical virology.

[40]  U. Völker,et al.  BLOOD COMPONENTS: A novel approach to pathogen reduction in platelet concentrates using short‐wave ultraviolet light , 2009, Transfusion.

[41]  Michael D. Ball,et al.  Investigation of the hydrophobic recovery of various polymeric biomaterials after 172 nm UV treatment using contact angle, surface free energy and XPS measurements , 2009 .

[42]  T. Müller,et al.  Sterilization of platelet concentrates at production scale by irradiation with short‐wave ultraviolet light , 2009, Transfusion.

[43]  C. Kessler,et al.  Fresh frozen plasma prepared with amotosalen HCl (S‐59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies , 2005, Transfusion.

[44]  H. Klein,et al.  Pathogen inactivation: making decisions about new technologies , 2007, Transfusion.

[45]  Kong-Thon Tsen,et al.  Selective inactivation of micro-organisms with near-infrared femtosecond laser pulses , 2007 .

[46]  Shaw-Wei D Tsen,et al.  Inactivation of viruses with a very low power visible femtosecond laser , 2007 .

[47]  P. Lyons,et al.  DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus. , 1995, The Journal of general virology.

[48]  Shaw-Wei D Tsen,et al.  Studies of inactivation of encephalomyocarditis virus, M13 bacteriophage, and Salmonella typhimurium by using a visible femtosecond laser: insight into the possible inactivation mechanisms. , 2011, Journal of biomedical optics.

[49]  J. Cadet,et al.  Individual determination of the yield of the main UV-induced dimeric pyrimidine photoproducts in DNA suggests a high mutagenicity of CC photolesions. , 2001, Biochemistry.